Influence of socio-economic factors on diabetes care

International Journal of Diabetes in Developing Countries

Volumn 21, Issue 2, 2001, Pages 77-85

  Anil, Kapur ^a  

^a Maruti Suzuki India Ltd   (India)

Author keywords

Bangalore Urban Diabetes Study; Complications; Direct health cost; Economic factors; Economic value of individual; Health care delivery; Indirect health cost; Risk factors

Indexed keywords

EID: 52549110793     PISSN: 09733930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ahuja MMS. Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS ed. Epidemiology of diabetes in developing countries. New Delhi: Interprint, 1979:29-38.
2. Ramachandran A, Snehlata C. NIDDM in India and Indians: is it increasing? Bull IDF 1995;40:27-9.
3. Ramachandran A, Snehlata C, Kapur A et al. National urban diabetes survey. Paper presented at Diabetes in Asia Meeting, Chennai, Feb 18-20, 2001.
4. Ramaiya KL, Kodali VRR, Alberti KGMM. Epidemiology of diabetes in Asians of the Indian sub-continent. Diabetes Metab Rev 1990;6:125-46.
5. Zimmet P. Challenges in diabetes epidemiology - from West to the rest. Diabetes Care 1992;15:232-52.
6. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections.
7. Kapur A, Shishoo S, Ahuja MMS, Sen V, Mankame K. Diabetes care in India - Patients' perceptions attitudes and practices (DIPPAP - 1 Study). Int J Diab Dev. Countries 1997;17:2-12.
8. International Diabetes Federation. Lowering the price of ignorance. A world view on diabetes education. Brussels 1995.
9. Carney T, Helliwell C. Effect of structured postgraduate medical education on the care of patients with diabetes. Brit J Gen Pract 1995;45:149-51.
10. Assal JP. Cost Effectiveness of diabetes education for chronic diseases. Pharmaco Economics 1995; 8 (Suppl. 1):68-71
11. Javitt JC. Cost savings associated with detection and treatment of diabetic eye disease. Pharmaco Economics 1995; 8 (Suppl 1): 33-9.
12. Johnsen KB. The costs of nephropathy in type 2 Diabetes. Pharmaco Economics 1995; 8 (Suppl 1): 38-45.
13. Rayappa PH, Raju KNM, Kapur A, Bjork S, Sylvist C, DilipKumar KM. The Impact of socio-economic factors on diabetes care. Int J Diab Dev. Countries 1999;19:7-16.
14. Rayappa PH, Raju KNM, Kapur A, Bjork S, Sylvist C, DilipKumar KM. Economic costs of diabetes care. The Bangalore urban district diabetes study. Int J Diab Dev. Countries 1999;19:87-96.
15. Hermann WH, Eastman RC. The effects of treatment on the direct costs of diabetes. Diabetes Care 1998; 21 (Suppl 3): C19-C24.
16. The economics of diabetes and diabetes care - a report of diabetes health economics study group. Gruber W, Lander T, Leese B, Songer T, Williams R. eds. An IDF, WHO Publication 1997.
17. Rubin JR, Altmann WM, Mendelson DN. Health care expenditures for people with diabetes mellitus 1992. J Clin Endocrinol Metab 1994;78:809A-F.
18. World Bank. World development report 1993: Investing in health, world development indicators. Oxford. Oxford university press, 1993;213-214.
19. Kapur A. Cost of diabetes in India - The CODI study paper presented at the Novo Nordisk Diabetes Update Bangalore, Feb 2000.
20. Shobhana R, Rama Rao P, Lavanya A, Williams R, Vijay V, Ramachandran A. Expenditure on health care incurred by diabetic subjects in a developing country - a study from Southern India. Diabetes Research and Clinical Practice. 2000;48:37-42.
21. Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Ram Moorthi S, Pendsey S, Sahay BK and the Diab Care Asia - India Study Group. Diabetes Care in India -Current Status. Under Publication JAPI
22. DiabCare Asia- A survey - Study on diabetes management and diabetes complication. Status in Asian countries. Final report on outcome data collection and analysis. Novo Nordisk Healthcare, Asia Pacific Centre, Singapore
23. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. Diabetes Care 1997;20:292-98.
24. Tercyak KP Jr., Kirkpatrick KA, Johnson SB, Silverstein JH. Offering a randomized trial of intensive therapy for IDDM to adolescents - Reasons for refusal, patient characteristics and recruiter effects. Diabetes Care 1998,21:213-5.